Gao, Chao
Zhu, Bin
Liu, Jianzheng
Jiang, Zhiwei
Hu, Tao
Wang, Qiong
Liu, Yi
Yuan, Ming
Li, Fei
Zhang, Ruining
Xia, Jielai
Onuma, Yoshinobu
Wang, Duolao
Serruys, Patrick
Tao, Ling
,
Article History
Received: 11 December 2023
Accepted: 4 January 2024
First Online: 20 January 2024
Declarations
:
: This study will be conducted according to the principles outlined in the Declaration of Helsinki, the Ethical Guidelines for Medical and Health Research Involving Human Subjects, and all other applicable laws and regulations in China. All patients must provide written informed consent. The institutional review board at Xijing Hospital (KY20212080-F-1) and the other 40 participating centers in China have approved this study protocol.
: Not applicable.
: Dr Serruys reported receiving personal fees from Sahajanand Medical Technologies, Novartis, Merillife, Xeltis, and Philips/Volcano outside the submitted work. No other disclosures were reported.